Giorgio Frega

1.4k total citations
55 papers, 865 citations indexed

About

Giorgio Frega is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giorgio Frega has authored 55 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 30 papers in Oncology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giorgio Frega's work include Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Gallbladder and Bile Duct Disorders (12 papers). Giorgio Frega is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Gallbladder and Bile Duct Disorders (12 papers). Giorgio Frega collaborates with scholars based in Italy, United States and Japan. Giorgio Frega's co-authors include Giovanni Brandi, Andrea Palloni, Alessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, Stefania De Lorenzo, Alessandro Di Federico, Francesca Abbati, Maria Aurelia Barbera and Mariacristina Di Marco and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Giorgio Frega

47 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giorgio Frega Italy 16 459 384 235 190 155 55 865
Andrea Palloni Italy 16 489 1.1× 430 1.1× 253 1.1× 197 1.0× 167 1.1× 67 890
Pin-Wen Lin Taiwan 17 385 0.8× 383 1.0× 262 1.1× 230 1.2× 143 0.9× 34 924
Ho-Yeong Lim South Korea 17 345 0.8× 173 0.5× 308 1.3× 301 1.6× 143 0.9× 31 863
Changqing Xie United States 14 465 1.0× 147 0.4× 116 0.5× 165 0.9× 129 0.8× 48 745
Yabing Cao China 15 350 0.8× 131 0.3× 135 0.6× 191 1.0× 182 1.2× 52 811
Yoshihiro Tokuhisa Japan 14 303 0.7× 136 0.4× 157 0.7× 184 1.0× 95 0.6× 32 601
Haosheng Jin China 16 294 0.6× 214 0.6× 200 0.9× 420 2.2× 177 1.1× 52 913
Sojun Hoshimoto Japan 16 493 1.1× 289 0.8× 215 0.9× 166 0.9× 54 0.3× 48 775
Hirofumi Shirakawa Japan 15 700 1.5× 311 0.8× 210 0.9× 319 1.7× 263 1.7× 30 1.2k
Takayuki Hamatsu Japan 14 302 0.7× 365 1.0× 237 1.0× 277 1.5× 377 2.4× 36 995

Countries citing papers authored by Giorgio Frega

Since Specialization
Citations

This map shows the geographic impact of Giorgio Frega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Frega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Frega more than expected).

Fields of papers citing papers by Giorgio Frega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgio Frega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Frega. The network helps show where Giorgio Frega may publish in the future.

Co-authorship network of co-authors of Giorgio Frega

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Frega. A scholar is included among the top collaborators of Giorgio Frega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Frega. Giorgio Frega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monte, Anne De, Alessandro Rizzo, Simona Tavolari, et al.. (2025). Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives. International Journal of Molecular Sciences. 26(24). 11961–11961.
2.
Aiba, Hisaki, Alberto Righi, Paolo Spinnato, et al.. (2024). Histological and imaging features of myoepithelial carcinoma of the bone and soft tissue. Skeletal Radiology. 53(12). 2617–2625. 1 indexed citations
3.
Ricci, Angela Dalia, Alessandro Rizzo, Rosalba D’Alessandro, et al.. (2024). Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications. Cancers. 16(20). 3542–3542. 4 indexed citations
4.
Rutkowski, Piotr, Anna Szumera‐Ciećkiewicz, Agnieszka Zając, et al.. (2023). 1969P Intratumoral immune infiltrates in chondrosarcoma (ChS). Annals of Oncology. 34. S1052–S1052. 2 indexed citations
5.
Frega, Giorgio, Fernando P. Cossío, Jesús M. Bañales, et al.. (2023). Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis. Cells. 12(16). 2098–2098. 18 indexed citations
6.
Laurenzi, Andrea, Giovanni Brandi, Enrico Prosperi, et al.. (2023). Can repeated surgical resection offer a chance of cure for recurrent cholangiocarcinoma?. Langenbeck s Archives of Surgery. 408(1). 102–102. 4 indexed citations
7.
Rizzo, Alessandro, Massimiliano Salati, Giorgio Frega, et al.. (2021). Second-line chemotherapy (2L) in elderly patients with advanced biliary tract cancer (ABC): A multicenter real-world study.. Journal of Clinical Oncology. 39(3_suppl). 322–322. 3 indexed citations
8.
Frega, Giorgio, Oliver Kepp, Daniela Turchetti, et al.. (2021). Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms. Translational Oncology. 14(12). 101224–101224. 3 indexed citations
9.
Rizzo, Alessandro, Angela Dalia Ricci, Alessandro Di Federico, et al.. (2021). Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?. Frontiers in Oncology. 11. 803133–803133. 86 indexed citations
10.
Federico, Alessandro Di, Valentina Tateo, Claudia Parisi, et al.. (2021). Hacking Pancreatic Cancer: Present and Future of Personalized Medicine. Pharmaceuticals. 14(7). 677–677. 39 indexed citations
11.
Rizzo, Alessandro, et al.. (2020). Experimental HER2- targeted therapies for biliary tract cancer. Expert Opinion on Investigational Drugs. 30(4). 389–399. 11 indexed citations
12.
Rizzo, Alessandro, Simona Tavolari, Angela Dalia Ricci, et al.. (2020). Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures. Cancers. 12(11). 3256–3256. 8 indexed citations
13.
Rizzo, Alessandro, Angela Dalia Ricci, Andrea Palloni, et al.. (2020). Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow. Anticancer Research. 40(6). 3013–3030. 63 indexed citations
14.
Ricci, Angela Dalia, Alessandro Rizzo, Simona Tavolari, et al.. (2020). The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma. In Vivo. 34(6). 3421–3429. 15 indexed citations
15.
Ricci, Angela Dalia, Giorgio Frega, Andrea Palloni, et al.. (2020). How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysis. In Vivo. 34(4). 1701–1714. 28 indexed citations
16.
Palloni, Andrea, Giorgio Frega, Francesca Abbati, et al.. (2019). An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone. Anti-Cancer Drugs. 30(4). 428–430. 1 indexed citations
17.
Lorenzo, Stefania De, Francesco Tovoli, Maria Aurelia Barbera, et al.. (2018). Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept. Scientific Reports. 8(1). 9997–9997. 83 indexed citations
18.
Garajová, Ingrid, Giorgio Frega, Andrea Palloni, et al.. (2017). The best overall response to the first-line but not to the second-line treatment correlates with outcome of metastatic right-sided and left-sided colon cancer. Annals of Oncology. 28. iii105–iii106.
19.
Ravaioli, Matteo, Alessandro Cucchetti, Antonio Daniele Pinna, et al.. (2017). The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation. Scientific Reports. 7(1). 11305–11305. 14 indexed citations
20.
Palloni, Andrea, Maria Aurelia Barbera, Giorgio Frega, et al.. (2016). Left versus right side primary tumor: the correlation with clinical outcome of patients with resected stage II and III colorectal cancer. Annals of Oncology. 27. iv49–iv49. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Palloni Breakdown of academic impact, for papers by Pin-Wen Lin Breakdown of academic impact, for papers by Ho-Yeong Lim Breakdown of academic impact, for papers by Changqing Xie Breakdown of academic impact, for papers by Yabing Cao Breakdown of academic impact, for papers by Yoshihiro Tokuhisa Breakdown of academic impact, for papers by Haosheng Jin Breakdown of academic impact, for papers by Sojun Hoshimoto Breakdown of academic impact, for papers by Hirofumi Shirakawa Breakdown of academic impact, for papers by Takayuki Hamatsu
Rankless by CCL
2026